ALX Oncology (ALXO) vs Canton Strategic (CNTN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Canton Strategic (CNTN) has outperformed ALX Oncology (ALXO) over the past year, losing 33.2% versus a loss of 35.6%. ALX Oncology is the larger company by market cap ($172.8 million vs $168.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALXO | CNTN |
|---|---|---|
| Share price | $1.25 | $2.11 |
| Market cap | $172.85M | $168.13M |
| 1-day change | +5.93% | +1.44% |
| YTD return | +10.62% | -30.36% |
| 1-year return | -35.57% | -33.23% |
| 5-year return | -97.88% | — |
| EPS (TTM) | $-1.13 | $-0.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.66 | $6.89 |
| 52-week low | $1.05 | $1.75 |
| Distance from 52-week high | -53.01% | -69.38% |
| Analyst consensus | none | — |
| Avg. price target upside | +268.00% | — |
| Average volume | 1.04M | 758.86K |
| Shares outstanding | 138.28M | 79.68M |
| Employees | 48 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ALX Oncology
ALXO stock →ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company's lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 48 employees
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
ALXO vs CNTN FAQ
Which is bigger, ALX Oncology or Canton Strategic?
ALX Oncology (ALXO) is larger, with a market capitalization of $172.85M compared with $168.13M for Canton Strategic (CNTN).
Which stock has performed better over the past year, ALXO or CNTN?
CNTN returned -33.23% over the past 12 months, compared with -35.57% for ALXO (price return, excluding dividends). Past performance does not predict future results.
Are ALX Oncology and Canton Strategic in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.